After finalizing guidelines for examining computer related, biotechnological and traditional knowledge patent applications, the Indian patent office released guidelines for examination of pharmaceutical patent applications. The pharmaceutical sector has always enjoyed an unusual prominence in debates about IP policy, and has always been the subject of national and international controversies. The original pharma patent examination guidelines (which can be accessed here) was open for public comments. Stakeholders met and discussed the guidelines extensively. Here stakeholders refer to a person interested...
↧